— Know what they know.
Not Investment Advice

RMTG OTC

Regenerative Medical Technology Group Inc.
1W: -12.3% 1M: -27.5% 3M: +97.8% YTD: +25.7%
$0.06
-0.00 (-5.72%)
 
Weekly Expected Move ±16.7%
$0 $0 $0 $0 $0
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 39 · $743245 mcap · 12M float · 0.769% daily turnover · Short 30% of daily vol

Supply Chain Overview

9 relationships
9
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2021-06-24
Earliest Filing
2023-12-13
Latest Filing
partner: 6 target: 2 investor: 1

Counterparties (Filed by RMTG)

9 relationships

Companies named in RMTG's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
GHS GHST investor Agreed to provide up to $10,000,000 in equity financing and purchase shares via put options. 2023-12-13 View
Global Stem Cells Group Inc. — target Target company acquired in a stock purchase agreement for 50,000,000 shares of common stock. 2022-03-23 View
Lans Holdings Inc. — partner Entity that assigned rights and obligations in the Letter of Intent to the registrant. 2022-03-23 View
Lans Holdings Inc. — partner Assigned rights and obligations in the Binding Letter of Intent to Meso Numismatics Inc. 2021-08-19 View
Global Stem Cells Group Inc. — target Target company acquired by Meso Numismatics Inc. in a stock purchase transaction. 2021-08-19 View
ETC (Enterprise Technology Consulting) — partner Consulting partner with whom Meso Numismatics Inc. entered into a Consulting Agreement. 2021-08-19 View
Global Stem Cells Group Inc. — partner Counterparty to Assignment and Assumption Agreement and Stock Purchase Agreement 2021-06-24 View
Lans Holdings Inc. — partner Counterparty to Assignment and Assumption Agreement; assigned rights to Company 2021-06-24 View
Benito Novas — partner Counterparty to Assignment and Assumption Agreement and Stock Purchase Agreement 2021-06-24 View
Recent 8-K Filings (11)
Filing Date Description Type SEC
2026-08-25 Other Events; Exhibits View
2025-05-21 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2024-11-19 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2024-10-24 Other Events View
2024-05-23 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2023-12-13 Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme Agreement View
2023-09-27 Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits View
2022-03-23 Entry into Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Unregi Agreement Acquisition View
2021-12-02 Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits View
2021-08-19 Entry into Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Unregi Agreement Acquisition View
2021-06-24 Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Material Modifica Agreement View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms